rs1553770510
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_032638.5(GATA2):c.1084C>T(p.Arg362Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R362R) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 33)
Consequence
GATA2
NM_032638.5 stop_gained
NM_032638.5 stop_gained
Scores
3
3
1
Clinical Significance
Conservation
PhyloP100: 5.64
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 50 pathogenic variants in the truncated region.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 3-128481878-G-A is Pathogenic according to our data. Variant chr3-128481878-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 435281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GATA2 | NM_001145661.2 | c.1084C>T | p.Arg362Ter | stop_gained | 6/7 | ENST00000487848.6 | |
GATA2 | NM_032638.5 | c.1084C>T | p.Arg362Ter | stop_gained | 5/6 | ENST00000341105.7 | |
GATA2 | NM_001145662.1 | c.1042C>T | p.Arg348Ter | stop_gained | 5/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GATA2 | ENST00000341105.7 | c.1084C>T | p.Arg362Ter | stop_gained | 5/6 | 1 | NM_032638.5 | P1 | |
GATA2 | ENST00000487848.6 | c.1084C>T | p.Arg362Ter | stop_gained | 6/7 | 1 | NM_001145661.2 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 genomes
?
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome ? Cov.: 33
GnomAD4 genome
?
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 28, 2023 | Observed in individuals with a personal or family history consistent with pathogenic variants in this gene (Zhang 2015, Lovell 2016, Bluteau 2018, Donadieu 2018, Polat 2018, McReynolds 2019); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27266944, 34670919, 32098966, 29146883, 25239263, 30578959, 29724903, 28440875, 30101490, 31753093, 30894283, 33363905, 28104920, 35753512, 34529785) - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 03, 2023 | PP1, PM2_supporting, PM6, PS4_moderate, PVS1 - |
Leukemia, acute myeloid, susceptibility to Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 24, 2015 | - - |
GATA2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 13, 2024 | The GATA2 c.1084C>T variant is predicted to result in premature protein termination (p.Arg362*). This variant has been reported in a number of patients with GATA2-related disorders (see for example Donadieu et al. 2018. PubMed ID: 29724903; Bluteau et al. 2018. PubMed ID: 29146883). This variant is not present in a large population database (https://gnomad.broadinstitute.org/) and has been interpreted as Pathogenic/Likely pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/435281/). Nonsense variants in GATA2 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 29, 2023 | This sequence change creates a premature translational stop signal (p.Arg362*) in the GATA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATA2 are known to be pathogenic (PMID: 21670465, 23223431). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of GATA2-related conditions (PMID: 27266944, 29146883, 29724903, 32098966). ClinVar contains an entry for this variant (Variation ID: 435281). For these reasons, this variant has been classified as Pathogenic. - |
Deafness-lymphedema-leukemia syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Deafness-lymphedema-leukemia syndrome;CN300066:GATA2 deficiency with susceptibility to MDS/AML Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Molecular Pathology Research Laboratory, SA Pathology | Jul 06, 2021 | PVS1, PS4, PM2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A;A
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at